GlassScriptPhysician profile
Lesley A Harcar
NPI 1528399011
$14,215.14
in general payments reported to CMS, 2019-2025
32 companies · $2,974 in 2025
The $2,974 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,335 · 2022: $3,077 · 2023: $3,021 · 2024: $2,808 · 2025: $2,974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,700 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,699.79 |
| Education | $103.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,983.80 | 2021-2025 | |
| Janssen Biotech, INC. | $1,217.13 | 2021-2025 | Tremfya, Stelara, Simponi Aria |
| Genzyme Corporation | $1,200.41 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $1,130.82 | 2021-2025 | Odomzo, Ilumya, Blu-U |
| Novartis Pharmaceuticals Corporation | $939.21 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $757.35 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $627.05 | 2021-2025 | Dupixent |
| Ucb, INC. | $625.80 | 2021-2025 | Bimzelx, Cimzia |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $585.16 | 2021-2025 | Siliq, Cabtreo, Jublia |
| Lilly USA, LLC | $577.83 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Galderma Laboratories, L.P. | $533.44 | 2021-2025 | Oracea, Aklief, Twyneo |
| Incyte Corporation | $478.88 | 2021-2025 | Opzelura |
| Pfizer INC. | $457.44 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $452.88 | 2022-2025 | Sotyktu |
| Mayne Pharma Commercial LLC | $393.00 | 2021-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $353.40 | 2021-2024 | Otezla |
| Dermavant Sciences, INC. | $204.13 | 2023-2024 | Vtama |
| Organon LLC | $161.54 | 2023-2025 | Hadlima, Vtama |
| Vyne Pharmaceuticals INC. | $157.56 | 2021 | |
| Leo Pharma INC. | $78.63 | 2025 | Adbry, Anzupgo |
| Journey Medical Corporation | $62.23 | 2022-2025 | |
| Allergan, INC. | $38.14 | 2021-2022 | |
| Almirall LLC | $35.76 | 2021-2024 | Klisyri |
| Paratek Pharmaceuticals, INC. | $34.93 | 2021-2023 | Nuzyra |
| Biofrontera INC. | $22.45 | 2025 | Ameluz |
| Medtronic, INC. | $18.63 | 2021 | |
| Botanix Sb INC | $17.30 | 2025 | Sofdra |
| Medimetriks Pharmaceuticals, INC. | $16.59 | 2022 | |
| Nabriva Therapeutics, Plc | $15.00 | 2021 | |
| Dermira, INC. | $14.40 | 2021 | |
| Bausch Health US, LLC | $12.58 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lesley Harcar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.